Fresenius SE KGaAXSWX:FRE 71 Earnings per Share (Diluted) is CHF2.41 as of Mar. 2026. GuruFocus rates XSWX:FRE with a GF Score™ of 71/100 and a GF Value™ of CHF33.42 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 511 Healthcare Providers & Services companies, Fresenius SE KGaA ranks worse than 73.58% on this metric.
Fresenius SE KGaA's EPS (Basic) for the
three
months ended in Mar. 2026 was CHF0.70.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was CHF2.41.
During the past 12 months, Fresenius SE KGaA's average EPS without NRIGrowth Rate was 15.80% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was -7.00% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was -4.00% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was 0.30% per year.
During the past 13 years, Fresenius SE KGaA's highest 3-Year average EPS without NRI Growth Rate was 38.30% per year. The lowest was -18.60% per year. And the median was 5.70% per year.
Fresenius SE KGaA (XSWX:FRE) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Fresenius SE KGaA Earnings per Share (Diluted) Related Terms
Fresenius SE KGaA Earnings per Share (Diluted) Historical Data
* Premium members only.
The historical data trend for Fresenius SE KGaA's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fresenius SE KGaA Earnings per Share (Diluted) Chart
XSWX:FRE vs HCA, THC, DVA: Earnings per Share (Diluted) Comparison
For the Medical Care Facilities subindustry, Fresenius SE KGaA's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fresenius SE KGaA PE Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fresenius SE KGaA's PE Ratio distribution charts can be found below:
* The bar in red indicates where Fresenius SE KGaA's PE Ratio falls into.
Fresenius SE KGaA Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
Fresenius SE KGaA's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2025 is calculated as
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF2.41
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
What does a Earnings per Share (Diluted) of CHF2.41 mean?
Fresenius SE KGaA (XSWX:FRE) has a Earnings per Share (Diluted) of CHF2.41 as of Mar. 2026. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Fresenius SE KGaA and its competitors. According to the industry distribution chart, Fresenius SE KGaA ranks #376 out of 511 companies in the Healthcare Providers & Services industry, placing it in the top 73.6%.
Is Fresenius SE KGaA's Earnings per Share (Diluted) too high?
Fresenius SE KGaA's current Earnings per Share (Diluted) is CHF2.41. Based on the distribution chart, Fresenius SE KGaA ranks #376 out of 511 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Fresenius SE KGaA has a GF Score™ of 71/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fresenius SE KGaA's Earnings per Share (Diluted) compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fresenius SE KGaA ranks #376 out of 511 companies for Earnings per Share (Diluted). This places Fresenius SE KGaA in the lower half of its industry. The industry median Earnings per Share (Diluted) is 11.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Healthcare Providers & Services company?
The median Earnings per Share (Diluted) among Healthcare Providers & Services companies is 11.50, based on 511 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Fresenius SE KGaA and its competitors. For the Healthcare Providers & Services industry, the median Earnings per Share (Diluted) is 11.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fresenius SE KGaA's current Earnings per Share (Diluted) is CHF2.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius SE KGaA stock overvalued right now?
Based on GuruFocus' analysis, Fresenius SE KGaA (XSWX:FRE) is currently considered Modestly Overvalued. The stock's GF Value™ is CHF33.42, compared to a current price of CHF37.79 — trading 13.1% above its estimated fair value. The current Earnings per Share (Diluted) is CHF2.41. Fresenius SE KGaA's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For Fresenius SE KGaA (XSWX:FRE), the current Earnings per Share (Diluted) is CHF2.41 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fresenius SE KGaA (XSWX:FRE) Overvalued in 2026?
Based on GuruFocus' analysis, Fresenius SE KGaA stock appears to be overvalued.
The current stock price of CHF37.79 is trading 13.1% above its estimated GF Value™ of CHF33.42.
GuruFocus considers Fresenius SE KGaA to be Modestly Overvalued.
Key valuation signals for XSWX:FRE:
Earnings per Share (Diluted): CHF2.41
GF Value™: CHF33.42 vs. price of CHF37.79 (13.1% above fair value)
No single metric tells the full story. See the XSWX:FRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fresenius is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain.
71GF Score
Get the complete analysis for XSWX:FRE
Earnings per Share (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:FRE has been successfully added to your 
